Patents by Inventor Maribeth V. Eiden

Maribeth V. Eiden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6033905
    Abstract: The present invention provides replication-defective hybrid retroviral vectors comprising GaLV components and methods for preparing and using such vectors. The vectors comprise a envelope component, a core component and a defective genome, at least one of which is derived from GaLV. The vectors can comprise the minimal cis acting sequences from GaLV that allow packaging of the defective genome in a hybrid virion.
    Type: Grant
    Filed: February 24, 1997
    Date of Patent: March 7, 2000
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Maribeth V. Eiden, Carolyn A. Wilson, Nicholas J. Deacon, David J. Hooker
  • Patent number: 5470726
    Abstract: Retrovirus packaging cell lines PG13 (ATCC No. CRL 10686) and PG13/LNc8 (ATCC No. CRL 10685), and retroviruses packaged by said cells.
    Type: Grant
    Filed: August 11, 1993
    Date of Patent: November 28, 1995
    Assignees: Fred Hutchinson Cancer Research Center, The United States of America as represented by the Department of Health and Human Services
    Inventors: A. Dusty Miller, Jose V. Garcia-Martinez, Maribeth V. Eiden, Carolyn A. Wilson